Keyphrases
Melanoma
100%
Programmed Death-ligand 1 (PD-L1)
100%
MiR-17-5p
100%
PD-L1 Downregulation
100%
Disease Aggressiveness
100%
MEK Inhibitor (MEKi)
77%
BRAF Inhibitor (BRAFi)
77%
PD-L1 Expression
44%
Metastatic Lesions
22%
Metastatic Melanoma
22%
Plasmatic
11%
Melanoma Cells
11%
Response Predictors
11%
Inverse Correlation
11%
3′-untranslated Region (3′-UTR)
11%
Post-transcriptional Mechanisms
11%
Gene Expression Profile
11%
Common Genes
11%
Worse Prognosis
11%
Resistant Cells
11%
Invasive Properties
11%
Direct Binding
11%
Gene Regulation
11%
Aggressive Behavior
11%
Cell Movement
11%
Constitutive Expression
11%
Unfavorable Outcome
11%
Resistant Cell Lines
11%
Tissue Biopsy
11%
Luciferase Reporter Assay
11%
Immune Infiltrates
11%
Post-transcriptional Events
11%
Neuroscience
Messenger RNA
100%
In Vitro
50%
Cell Line
50%
Gene Expression
50%
Luciferase
50%
Cell Migration
50%
Cell Movement
50%
3' Untranslated Region
50%
MEK Inhibitor
50%
Aggression
50%
Biochemistry, Genetics and Molecular Biology
Upregulation
100%
PD-L1
100%
Messenger RNA
14%
Gene Expression
7%
Cell Migration
7%
Immunity
7%
Luciferase
7%
Cell Movement
7%
Aggression
7%
3' Untranslated Region
7%
MEK Inhibitor
7%
Immunology and Microbiology
Upregulation
100%
Programmed Death-Ligand 1
100%
Cell Migration
7%
Gene Expression
7%
Immunity
7%
Melanoma Cell
7%
3' Untranslated Region
7%
Resistant Cell Line
7%